Cargando…
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response
AIMS: To determine the prevalence of polypoidal choroidal vasculopathy (PCV) in patients with presumed neovascular age-related macular degeneration (AMD) who were considered poor responders to ranibizumab. METHODS: Caucasian patients with suspected neovascular AMD, presumed to be choroidal neovascul...
Autores principales: | Hatz, Katja, Prünte, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913166/ https://www.ncbi.nlm.nih.gov/pubmed/24246375 http://dx.doi.org/10.1136/bjophthalmol-2013-303444 |
Ejemplares similares
-
Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Matsumiya, Wataru, et al.
Publicado: (2011) -
Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Jin, Ki Won, et al.
Publicado: (2021) -
Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up
por: Steinemann, Alexandra, et al.
Publicado: (2021) -
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Kondo, Naoshi, et al.
Publicado: (2009) -
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019)